Organoid: a promising solution to current challenges in cancer immunotherapy

Nature·Dec 12

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Organoids are being explored as a potential solution to challenges in cancer immunotherapy. Research is underway to utilize patient-derived organoids as a preclinical platform to overcome these challenges. The use of organoids in cancer research is part of a broader field of study that also encompasses regenerative medicine and drug discovery.

Full coverage

Unlocking the potential of organoids in modern drug discovery

News-Medical·23h ago

Patient-derived organoids (PDOs): a novel preclinical platform to overcome challenges in cancer immunotherapy

Frontiers·Jan 19

Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects

Wiley Online Library·Jan 5

Cancer nanomedicine: Concepts, promises, and challenges

ScienceDirect.com·Sep 11

Silicon Valley millionaire Bryan Johnson says he'll make humans immortal by 2039—he just needs to sort out ‘buggy’ issues like ‘mistakenly causing cancer’ first

Fortune·Dec 17

Brain organoids as precision models for neurodegenerative diseases: from disease modeling to drug discovery

Frontiers·Jan 30

Bioelectronic Interfaces and Sensors for Neural Organoids

Nature·Sep 15

Patient-derived organoids in human cancer: A platform for fundamental research and precision medicine

Medical Xpress·Mar 25

View original report at Nature ↗

Fetching the latest headlines…